Skip to content

Homoeopathic Treatment of Diabetes

Comparative study of uranium nitricum 30 versus individualized homoeopathic medicine in management of type 2DM - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/081167
Enrollment
60
Registered
2025-02-24
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E116- Type 2 diabetes mellitus with other specified complications

Interventions

Intervention1: Individualized Homoeopathic Medicine: Intervention is planned as administrating individualized homoeopathic medicine to a group of 30 patients suffering from type 2 diabetes mellitus af

Sponsors

Dr Kavya Singh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients suffering from Type 2 DM (Hb A1c- 6.5% or higher) at the time of screening. 2. Patients with random blood glucose 200 mg/dl and above. 3. Patients of age group 30-70 years. 4. Patients of both sexes and all religions. 5. Patients who are previously diagnosed with Type 2 Diabetes Mellitus and are taking Oral Anti Glycemic Drugs. 6. Patient who gives their valid consent to participate in the study.

Exclusion criteria

Exclusion criteria: 1. Patients suffering from Type 2 DM (Hb A1c --more than 10%) at the time of screening. 2. Patients with secondary complications of diabetes like nephropathy and retinopathy. 3. Patients who are taking insulin injections. 4. Patient unwilling to participate in the study. 5. Pregnant women and lactating mothers.

Design outcomes

Primary

MeasureTime frame
To compare the changes in random blood glucose level before and after treatment in patients with type 2 diabetes mellitus at baseline and after 6 months of treatment to compare effectiveness of uranium nitricum 30 and individualized homoeopathic medicine.Timepoint: 12weeks,24weeks

Secondary

MeasureTime frame
To compare changes in DSC-R (Diabetes Symptom Checklist-Revised) at baseline and every 3 months of treatment.Timepoint: 12weeks ,24 weeks

Countries

India

Contacts

Public ContactDr Shiv Shankar Pal

State National Homoeopathic Medical College and Hospital, Lucknow

singhkavya37@gmail.com7905334785

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026